ROL | Ticker Profile - Titan Protect

ROL

Rollins, Inc.

Industrials · Environmental & Facilities Services · US

$47.10

Data: 2026-05-15

✓ ETHICAL PASS

MODERATE MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$25.8B

Total market value of the company

Trailing P/E

49.11

Expensive — high growth expected

Forward P/E

38.39

Based on estimated future earnings — lower means cheaper

Rev Growth

+10.2%

Year-over-year revenue change

Profit Margin

13.8%

How much profit the company keeps from each dollar of revenue

ROE

38.7%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$64.25

+36% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 16 analysts covering this stock

About Rollins, Inc.

Rollins, Inc., through its subsidiaries, provides pest and wildlife control services and protection to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, food service, and logistics. In addition, the company offers termite protection and ancillary services for both residential and commercial customers. It serves clients directly, as well as through franchisee operations. The company was formerly known as Rollins Broadcasting, Inc and changed its name to Rollins, Inc. in 1965. Rollins, Inc. was founded in 1901 and is headquartered in Atlanta, Georgia.

https://www.rollins.com

Country: United States Employees: 22,000 Industry: Personal Services

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

33.1% PASS

Debt must be below 33% of total assets

Cash Ratio

0.0% PASS

Interest-bearing cash below 33% of assets

Receivables

9.6% PASS

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Valuation

Fair Value Est.

$16.73

What our model estimates this business is worth per share

Margin of Safety

-181.5%

Trading above fair value — no margin of safety

Rating

OVERVALUED

Overall assessment combining ethics, valuation, and quality

Percentile

89.6th

Ranks in the top 10% of our 13,571 screened universe

Ethical Score

85.1

Valuation Score

30.5

Quality Score

81.3

Combined

62.9

Trading at $54, 220% above fair value of $17. Moderate competitive position. Passes all ethical screens. Ranks better than 59% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.487

Positive but modest risk-adjusted returns

Kelly Fraction

0.0348

Modest edge detected — smaller position warranted

Calmar Ratio

0.441

Drawdown risk outweighs the returns — higher risk profile

Annual Return

8.7%

Historical annualised return based on price data

Max Drawdown

-19.8%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.79

Less volatile than the market — more defensive

52W High

$66.14

29% below the year high

52W Low

$51.95

-9% above the year low

Avg Volume

2,976,906

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.1

Days it would take all short sellers to cover — higher means more crowded

Short % Float

3.0%

Low short interest — limited bearish positioning

Div Yield

1.4%

Annual dividend as a percentage of the share price

EPS (TTM)

$1.09

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

0.77

Moderate leverage — manageable

Current Ratio

0.65

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.47

Like current ratio but excludes inventory — stricter test

Gross Margin

52.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

16.1%

Profit from core operations before interest and tax

Free Cash Flow

$521M

Positive — the business generates more cash than it spends

Revenue (TTM)

$3.8B

Total revenue over the last 12 months

Net Income

$529M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$72.00

Target Median

$64.25

Target Low

$50.00

Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date	Insider	Title	Shares	Value
2026-04-30	WILSON JOHN F	Officer and Director	4,795	—
2026-04-29	GAHLHOFF JERRY JR	Chief Executive Officer	3,629	—
2026-04-28	GUNNING PATRICK J.	Director	2,692	—
2026-04-28	CARSON DONALD P	Director	2,692	—
2026-04-28	ROLLINS PAMELA R	Director	2,692	—
2026-04-28	ROLLINS TIMOTHY CURTIS	Director	2,692	—
2026-04-28	MORRISON GREGORY B.	Director	2,692	—
2026-04-28	HARDIN PAUL RUSSELL	Director	2,692	—
2026-04-28	SAMS LOUISE S.	Director	2,692	—
2026-04-28	BELL SUSAN R	Director	2,692	—

Source: SEC Form 4 filings via public data. View all insider activity at

Insider Intelligence

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
7 May2026	Tim Moore	Republican	buy	1K–15K
2026-05-07	Tim Moore	Republican	Purchase	1K–15K
2026-04-13	Ro Khanna	Democrat	Purchase	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Before you go